logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
Expert Opinion on Therapeutic Patents cover

Expert Opinion on Therapeutic Patents

IF4.6
Papers2592
Citations4317
Journal Papers 3021
Publication Date
delete
Helicase-primase inhibitors as next-generation anti-HSV agents: from current clinical status to structure–activity relationships and patent coverage
deleteExpert Opinion on Therapeutic Patents
IF4.6
delete2026-08-05
delete0
PREAI
deleteChristian Gege; Gerald Kleymann
deleteShare
deleteSave
New insights on anticancer glucocorticoid receptor modulators: a patent review (2020-present)
deleteExpert Opinion on Therapeutic Patents
IF4.6
delete2026-06-19
delete0
PREAI
deleteMartina Franzin; Marianna Lucafò; Debora Curci; Giuliana Decorti; Gabriele Stocco
deleteShare
deleteSave
An updated review of discoidin domain receptor 1 (DDR1) modulators (2020-present)
deleteExpert Opinion on Therapeutic Patents
IF4.6
delete2026-06-10
delete0
PREAI
deleteYunliang Zhang; Zhen Wang; Ke Ding
deleteShare
deleteSave
An update on PDGFR inhibitors: a patent review (2020 - present)
deleteExpert Opinion on Therapeutic Patents
IF4.6
delete2026-05-27
delete0
PREAI
deleteSisir Nandi; Sarfaraz Ahmed; Soubhik Barma; Rishita Dey; Asmita Samadder
deleteShare
deleteSave
Recent advances in the discovery of PKMYT1-targeting drugs: a patent review (2021–2025)
deleteExpert Opinion on Therapeutic Patents
IF4.6
delete2026-05-21
delete0
PREAI
deleteYazhou Wang; Chao Wang; Feng Ren; Alex Zhavoronkov; Xiao Ding
deleteShare
deleteSave
PCSK9 inhibitors: an updated patent review 2024–2025
deleteExpert Opinion on Therapeutic Patents
IF4.6
delete2026-05-21
delete0
PREAI
deleteEnrico Mario Alessandro Fassi; Marco Albani; Lorenza D’Adduzio; Erica Ginevra Milano; Carmen Lammi; Giovanni Grazioso
deleteShare
deleteSave
An updated patent review of histone deacetylase 6 inhibitors in neurodegenerative diseases (2020–2025)
deleteExpert Opinion on Therapeutic Patents
IF4.6
delete2026-05-20
delete0
PREAI
deleteSida Shen
deleteShare
deleteSave
A patent review of LPAR1 antagonists (2010 – present)
deleteExpert Opinion on Therapeutic Patents
IF4.6
delete2026-05-17
delete0
PREAI
deleteJiaxing Zhao; Yuxing Li; Wangshan Zheng; Yang Liu; Yan Yang; Yan Leng; Shiyu Wei; Jun Lou; Xiaofei Shang; Deping Tang
deleteShare
deleteSave
Small molecule agonists of Toll-like receptors 7 and 8: an updated patent review 2021 – 2025
deleteExpert Opinion on Therapeutic Patents
IF4.6
delete2026-05-15
delete0
PREAI
deleteAkash M. Patel; Natalia Chernyak; W. Michael Seganish
deleteShare
deleteSave
A patent review of VEGFR-2 inhibitors: an update (2022 – present)
deleteExpert Opinion on Therapeutic Patents
IF4.6
delete2026-04-26
delete0
PREAI
deleteThoraya A. Farghaly; Marwa F. Harras; Amani M. R. Alsaedi; Sami A. Al-Hussain; Nadia T. Al-Qurashi; Sayed M. Riyadh; Magdi E. A. Zaki; Shadia M. Hussein
deleteShare
deleteSave
Activin receptor-like kinase 5 (ALK5) inhibitors: a patent review (2013-present)
deleteExpert Opinion on Therapeutic Patents
IF4.6
delete2026-04-19
delete0
PREAI
deleteXin-Yi Huang; Chao-Qun Yu; Xin Wang; Zhen Guo; Cheng-Hua Jin
deleteShare
deleteSave
A patent review of NLRP3 inhibitors for inflammatory diseases (2023-present)
deleteExpert Opinion on Therapeutic Patents
IF4.6
delete2026-04-10
delete0
PREAI
deleteJannatun N. Namme; Yiming Xu; Elijah McClendon; Can Zhang; Shijun Zhang
deleteShare
deleteSave
An updated patent review of isoflavones and isocoumarins (2018–2024)
deleteExpert Opinion on Therapeutic Patents
IF4.6
delete2026-03-10
delete0
PREAI
deleteHidayat Hussain
deleteShare
deleteSave
5’-Ectonucleotidase (CD73) inhibitors: a patent review (2021-present)
deleteExpert Opinion on Therapeutic Patents
IF4.6
delete2026-03-05
delete0
PREAI
deleteZhaolin Wang; Anna Junker
deleteShare
deleteSave
Patent landscape and therapeutic evolution of mazdutide: a dual GLP-1/Glucagon receptor agonist for obesity and type 2 diabetes
deleteExpert Opinion on Therapeutic Patents
IF4.6
delete2026-03-01
delete0
PREAI
deleteAbdul Fasi, Mohammed
deleteShare
deleteSave
LSD1 inhibitors for anticancer therapy: an updated patent review (2022–2025)
deleteExpert Opinion on Therapeutic Patents
IF4.6
delete2026-02-26
delete0
PREAI
deleteZhoudong Zhang; Jiyu Li; Zitong Wang; Jiayi Zhou; Xiaolu Xiong; Wenjie Hou; Huanqiu Li
deleteShare
deleteSave
Patents involving monoamine oxidase (MAO): a comprehensive update (2022–2025) on its inhibitors and applications
deleteExpert Opinion on Therapeutic Patents
IF4.6
delete2026-02-25
delete0
PREAI
deleteMoataz A. Shaldam; Simone Carradori; Marwa Balaha; Paolo Guglielmi; Francesca Diomede; Ilaria D’Agostino; Haytham O. Tawfik
deleteShare
deleteSave
Novel fatty acid amide hydrolase (FAAH) inhibitors: a patent review from 2015 to 2025
deleteExpert Opinion on Therapeutic Patents
IF4.6
delete2026-02-04
delete0
PREAI
deleteLaura Landolfi; Margherita Brindisi; Valentina Onnis; Federica Moraca; Bruno Catalanotti
deleteShare
deleteSave
Recent advances in factor XII(a) inhibitors: an updated patent landscape (2020-present)
deleteExpert Opinion on Therapeutic Patents
IF4.6
delete2026-02-01
delete0
PREAI
deleteKalinin, Dmitrii V.
deleteShare
deleteSave
Protein tyrosine phosphatase 1B (PTP1B) inhibitors as potential anti-diabetes agents: updated patent review (2019–2023)
deleteExpert Opinion on Therapeutic Patents
IF4.6
delete2026-01-30
delete0
PREAI
deleteRafia Ashfaq; Hidayat Hussain
deleteShare
deleteSave